| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
231ABC-Transporter mediated efflux of aldehyde dehydrogenase reaction product: Implications for enumeration and isolation of functional blood progenitor cells
|
Balber, A.E.
|
|
2003
|
9 |
2 |
p. 131-
1 p.
|
artikel
|
| 2 |
156A clicnical trial of gene transfer to bone marrow CD34+ cells from ADA-deficient SCID subjects
|
Kohn, D.B.
|
|
2003
|
9 |
2 |
p. 112-
1 p.
|
artikel
|
| 3 |
3A critical role for CCR2 in the development of idiopathic pneumonia syndrome after allogeneic BMT
|
Hildebrandt, G.C.
|
|
2003
|
9 |
2 |
p. 61-62
2 p.
|
artikel
|
| 4 |
85 A critical role for CD4+CD25+ suppressor cells in controlling GVHD after DLI in murine bone marrow chimeras
|
Xia, G.
|
|
2003
|
9 |
2 |
p. 90-
1 p.
|
artikel
|
| 5 |
39 Acute renal failure following non-myeloablative hematopoietic stem cell transplantation — a multicenter study
|
Parikh, C.R.
|
|
2003
|
9 |
2 |
p. 76-
1 p.
|
artikel
|
| 6 |
66 Adding mycophenolate mofetil (MMF) and ATGAM to cyclosporin decreases severe GVHD and transplant-related mortality (TRM) after non-myeloablative allogeneic PBSC transplantation (mini-PBSCT)
|
Schwarer, A.P.
|
|
2003
|
9 |
2 |
p. 84-85
2 p.
|
artikel
|
| 7 |
60 Adenovirus infection (A1) and disease (AD) in pediatric matched unrelated donor bone marrow transplant (BMT) patients receiving either anti-thymocyte globulin (ATG) or campath during conditioning
|
Myers, G.D.
|
|
2003
|
9 |
2 |
p. 83-
1 p.
|
artikel
|
| 8 |
35 Adoptive transfer of HCMV PP65 — Peptide loaded DCS to improve HCMV=specific T cell reconstitution following allogeneic stem cell transplantation
|
Einsele, H.
|
|
2003
|
9 |
2 |
p. 74-
1 p.
|
artikel
|
| 9 |
68 A fluorescence-based assay suitable for monitoring NK activity in clinical settings
|
Storms, R.W.
|
|
2003
|
9 |
2 |
p. 85-
1 p.
|
artikel
|
| 10 |
32 Aldehyde dehydrogenase is expressed by primitive CD34+ hematopoietic progenitors
|
Storms, R.W.
|
|
2003
|
9 |
2 |
p. 73-
1 p.
|
artikel
|
| 11 |
208A limited sampling strategy (LSS) to target systemic exposure (SE) of busulfex (Busulfan) injection (IVBU) in pediatric patients (PEDS)
|
Lennon, S.
|
|
2003
|
9 |
2 |
p. 125-126
2 p.
|
artikel
|
| 12 |
207Allogeneic bone marrow transplantation for children with hematologic malignancies
|
Hale, G.A.
|
|
2003
|
9 |
2 |
p. 125-
1 p.
|
artikel
|
| 13 |
203Allogeneic bone marrow transplantation for children with myeloid hematologic malignancies
|
Hale, G.A.
|
|
2003
|
9 |
2 |
p. 124-
1 p.
|
artikel
|
| 14 |
72 Allogeneic bone marrow transplantation for myelofibrosis due to agnogenic myeloid metaplasia (AMM) and essential thrombocytosis (ET): Experience of two bone marrow transplant centers
|
Daly, A.
|
|
2003
|
9 |
2 |
p. 86-
1 p.
|
artikel
|
| 15 |
56 Allogeneic stem cell transplantation using high-dose cytarabine combined with G-SCF and TBI as conditioning for chronic myelogenours leukemia (CML) in advanced stage
|
Yamazaki, R.
|
|
2003
|
9 |
2 |
p. 82-
1 p.
|
artikel
|
| 16 |
64 Allografting with fludarabine and ATG after failed engraftment of autologous peripheral blood stem cells
|
Bayer, R.
|
|
2003
|
9 |
2 |
p. 84-
1 p.
|
artikel
|
| 17 |
123A-locus mismatch does not adversely influence outcome following related-donor stem cell transplantation (SCT)
|
Savoie, M.L.
|
|
2003
|
9 |
2 |
p. 102-
1 p.
|
artikel
|
| 18 |
253Alternate day ganciclovir/foscarnet (Gan/Fos) for cytomegalovirus prophylaxis in at risk allogeneic stem cell transplant related and unrelated recipients is 100% effective in preventing CMV infections
|
Shereck, E.B.
|
|
2003
|
9 |
2 |
p. 136-137
2 p.
|
artikel
|
| 19 |
126Alternative donor hematopoetic stem cell transplantation (HSCT) for acute and chronic lymphoid malignancies: 20 year experience of the leukemia/BMT program of British Columbia
|
Toze, C.
|
|
2003
|
9 |
2 |
p. 102-103
2 p.
|
artikel
|
| 20 |
246Ambisome® I mg/kg/day as empiric antifungal therapy in patients with prolonged neutropenia and fever
|
DeVoe, M.
|
|
2003
|
9 |
2 |
p. 134-135
2 p.
|
artikel
|
| 21 |
29 A multicenter study of allogeneic stem cell transplantation (ASCT) for advanced solid tumors
|
Blaise, D.P.
|
|
2003
|
9 |
2 |
p. 72-
1 p.
|
artikel
|
| 22 |
113Analysis of CD4+CD25+ T regulatory cell survival and function following in vitro and in vivo irradiation
|
Zimmerman, Z.F.
|
|
2003
|
9 |
2 |
p. 99-
1 p.
|
artikel
|
| 23 |
141An intent to treat analysis of chemotherapy versus allogeneic bone marrow transplant in first complete remission (CRI) for adult patients below the age 55 years with acute lymphoblastic leukemia (ALL): Results from Princess Margaret Hospital
|
Gupta, V.
|
|
2003
|
9 |
2 |
p. 107-
1 p.
|
artikel
|
| 24 |
27 A novel strategy for generating LMPI specific T cells utilizing artificial antigen presenting cells
|
Doubrovina, E.S.
|
|
2003
|
9 |
2 |
p. 71-
1 p.
|
artikel
|
| 25 |
135Anti-CD3 stimulated T regulatory cells do not inhibit syngeneic bone marrow progenitor cell proliferation
|
Dayao, Z.R.
|
|
2003
|
9 |
2 |
p. 105-
1 p.
|
artikel
|
| 26 |
13 Antigen presenting cells in the liver recruite activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease
|
Zhang, Y.
|
|
2003
|
9 |
2 |
p. 67-
1 p.
|
artikel
|
| 27 |
63 Anti-leukemic activity of chronic graft-versus-host disease following allogeneic bone marrow transplantation in adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia
|
Lee, S.
|
|
2003
|
9 |
2 |
p. 83-84
2 p.
|
artikel
|
| 28 |
117Anti-thymocyte globulin (ATG), low dose TBI and fludarabine (FLU) conditioning for allogeneic transplantation
|
Isola, L.
|
|
2003
|
9 |
2 |
p. 100-
1 p.
|
artikel
|
| 29 |
275A nurse is not a nurse! How to recruit and retain top nursing talent in pediatric stem cell transplantation
|
Talbert, G.
|
|
2003
|
9 |
2 |
p. 143-
1 p.
|
artikel
|
| 30 |
274A parent support program for children undergoing stem cell transplantation: The Duke University pediatric stem cell program model
|
Hungale, J.
|
|
2003
|
9 |
2 |
p. 143-
1 p.
|
artikel
|
| 31 |
14 A phase I/II study of recombinant human keratinocyte growth factor (KGF) in patients with high risk hematologic malignancies undergoing mismatched related or unrelated donor transplant
|
Reynolds, C.M.
|
|
2003
|
9 |
2 |
p. 67-
1 p.
|
artikel
|
| 32 |
197A pilot study of myeloablative (MA) autologous stem cell transplantation (Auto SCT) followed by reduced intensity (RI) allogeneic transplantation (ALLO SCT) in children and young adults with relapsed lymphoma
|
Bradley, M.
|
|
2003
|
9 |
2 |
p. 122-
1 p.
|
artikel
|
| 33 |
17 Application of immune-therapeutic interventions after allogeneic stem-cell transplantation based on MRD detection with combined morphological and cytogenetic analysis
|
Shimoni, A.
|
|
2003
|
9 |
2 |
p. 68-
1 p.
|
artikel
|
| 34 |
269A review of donor lymphocyte infusions used in non-myeloablative, T-cell depleted, allogeneic stem cell transplants in adults
|
Thompson, M.
|
|
2003
|
9 |
2 |
p. 142-
1 p.
|
artikel
|
| 35 |
108A role for the P75 but not the P55 TNFα receptor in the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation
|
Cooke, K.R.
|
|
2003
|
9 |
2 |
p. 97-
1 p.
|
artikel
|
| 36 |
ASBMT/IBMTR Workshop Descriptions
|
|
|
2003
|
9 |
2 |
p. A2-A7
nvt p.
|
artikel
|
| 37 |
265Assessing learning needs of stem cell transplant patients
|
Wood, L.L.
|
|
2003
|
9 |
2 |
p. 140-141
2 p.
|
artikel
|
| 38 |
4A successful approach of G-CSF primed haploidentical bone marrow transplantation without ex-vivo T cell depletion for high-risk leukemia
|
Xun, C.
|
|
2003
|
9 |
2 |
p. 63-
1 p.
|
artikel
|
| 39 |
Author index
|
|
|
2003
|
9 |
2 |
p. 147-150
4 p.
|
artikel
|
| 40 |
152Autologous blood and marrow transplantation (BMT) in older adults (60 years and older)
|
Burian, C.
|
|
2003
|
9 |
2 |
p. 111-
1 p.
|
artikel
|
| 41 |
200Autologous hematopoietic stem cell transplantation for treatment of multicentric castleman's disease/poems syndrome
|
Chamarthy, U.
|
|
2003
|
9 |
2 |
p. 123-
1 p.
|
artikel
|
| 42 |
225Autologous stem cell collection in polycythemia vera
|
Isola, L.
|
|
2003
|
9 |
2 |
p. 129-
1 p.
|
artikel
|
| 43 |
158Autologous Stem Cell Transplantation (ASCT) in multiple Myeloma (MM): Achievement of CR is associated with improved survival
|
Kumar, L.
|
|
2003
|
9 |
2 |
p. 113-
1 p.
|
artikel
|
| 44 |
10 Autologous stem cell transplantation (ASCT) in primary systemic amyloidosis (AL): The impact of selection criteria on outcome
|
Mollee, P.
|
|
2003
|
9 |
2 |
p. 66-
1 p.
|
artikel
|
| 45 |
146Autologus stem cell transplantation as postremission therapy for acute myeloid leukaemia
|
Candoni, A.
|
|
2003
|
9 |
2 |
p. 108-109
2 p.
|
artikel
|
| 46 |
191Barriers to second transplant for multiple myeloma in a randomized autologous tandem trial
|
Wilson, R.L.
|
|
2003
|
9 |
2 |
p. 120-
1 p.
|
artikel
|
| 47 |
74 Bayesian sensitivity analyses of 100-day survival with intravenous busulfan versus alternative myeloablative conditioning therapy in allogeneic stem cell transplantation (Allo-SCT) for chronic myelogenous leukemia (CML)
|
Thall, P.F.
|
|
2003
|
9 |
2 |
p. 87-
1 p.
|
artikel
|
| 48 |
278BMT-EZ: Innovative communication vehicle in tracking bone marrow transplant patients
|
Cruz, E.
|
|
2003
|
9 |
2 |
p. 144-
1 p.
|
artikel
|
| 49 |
240Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal occult hematological malignancies in asymptomatic individuals
|
Kiss, T.L.
|
|
2003
|
9 |
2 |
p. 132-133
2 p.
|
artikel
|
| 50 |
31 Bone marrow derived mesenchymal stem cells: Impact on neointestinal engineering
|
Gandia, C.
|
|
2003
|
9 |
2 |
p. 73-
1 p.
|
artikel
|
| 51 |
224Brain from blood in humans
|
Cogle, C.R.
|
|
2003
|
9 |
2 |
p. 129-
1 p.
|
artikel
|
| 52 |
36 Bronchoalveolar lavage (BAL) in patients (PTS) with pulmonary complications undergoing hematopoietic progenitor cell transplant (HPCT): A single center experience
|
Abbyankar, S.
|
|
2003
|
9 |
2 |
p. 74-
1 p.
|
artikel
|
| 53 |
53 Busulfan/melphalan/ATG (BU/MEL/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): The coblt experience
|
Wall, D.
|
|
2003
|
9 |
2 |
p. 81-
1 p.
|
artikel
|
| 54 |
237Caregiving strain following autologous BMT
|
Eldredge, D.
|
|
2003
|
9 |
2 |
p. 132-
1 p.
|
artikel
|
| 55 |
279Care of the autologous blood and marrow transplant patient in a fast paced clinic with a multidisciplinary team approach
|
Baughman, E.E.
|
|
2003
|
9 |
2 |
p. 144-
1 p.
|
artikel
|
| 56 |
83 Case report of a patient with adult T-cell leukemia/lymphoma (ATLL) 18 months after allogeneic matched related donor peripheral stem cell transplant
|
Stolar, K.
|
|
2003
|
9 |
2 |
p. 89-90
2 p.
|
artikel
|
| 57 |
95 CD83 antigen: A potential new target for graft versus host disease prevention
|
Munster, D.J.
|
|
2003
|
9 |
2 |
p. 93-
1 p.
|
artikel
|
| 58 |
52 CD150 as a potential marker for alloactivated CD4+25+ regulatory T cells
|
Browning, M.B.
|
|
2003
|
9 |
2 |
p. 80-
1 p.
|
artikel
|
| 59 |
1CD3, CD28 co-stimulated syngeneic T cells mediate GVL against murine myeloma: TH1/TC1 > TH2/TC2
|
Hou, J.W.
|
|
2003
|
9 |
2 |
p. 61-
1 p.
|
artikel
|
| 60 |
201CD34+ counts after etoposide and cyclophosphamide plus G-CSF mobilization versus G-CSF alone in multiple myeloma patients undergoing autologous transplantation
|
Pierce, T.N.
|
|
2003
|
9 |
2 |
p. 123-124
2 p.
|
artikel
|
| 61 |
90 CD25 expression distinguishes functionally distinct alloreactive CD4+CD134+ T cell subsets in acute GVHD
|
Maziarz, R.T.
|
|
2003
|
9 |
2 |
p. 92-
1 p.
|
artikel
|
| 62 |
147CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis (MS): Report of toxicity and treatment results at one year of follow-up in 15 patients
|
Carreras, E.
|
|
2003
|
9 |
2 |
p. 110-
1 p.
|
artikel
|
| 63 |
249Changing patterns of fungal infections in a blood and marrow transplant program
|
White, M.
|
|
2003
|
9 |
2 |
p. 135-
1 p.
|
artikel
|
| 64 |
183Clinical and quality of life monitoring in multiple sclerosis patients undergoing high dose chemotherapy and autologous stem cell transplantation
|
Novik, A.A.
|
|
2003
|
9 |
2 |
p. 119-
1 p.
|
artikel
|
| 65 |
127Combination sirolimus and tacrolimus immunoprophylaxis promotes engraftment of haploidentical and alternative donor stem cells with non-myeloablative conditioning in elderly and poor prognosis patients
|
Claxton, D.F.
|
|
2003
|
9 |
2 |
p. 103-
1 p.
|
artikel
|
| 66 |
46 Comparative outcome of unrelated hematopoietic stem cell transplantation (HSCT) with cord blood (CB) vs bone marrow (BM) in pediatric recipients
|
Dalle, J.
|
|
2003
|
9 |
2 |
p. 78-79
2 p.
|
artikel
|
| 67 |
199Comparison of three conditioning regimens for autologous stem cell transplantation in non-hodgkins lymphoma
|
Fein, S.G.
|
|
2003
|
9 |
2 |
p. 123-
1 p.
|
artikel
|
| 68 |
242Cytomegalovirus (CMV) gastrointestinal disease in allogeneic hematopoietic stem cell transplant recipients under preemptive therapy based on CMV antigenemia or polymerase chain reaction
|
Mori, T.
|
|
2003
|
9 |
2 |
p. 133-
1 p.
|
artikel
|
| 69 |
89 Delayed infusion of donor CD4+25+ T cells controls graft-versus-host disease while allowing an effective graft-versus-leukemia response
|
Jones, S.C.
|
|
2003
|
9 |
2 |
p. 91-92
2 p.
|
artikel
|
| 70 |
101Dendritic cells cultured with interferon plus GM-CSF can be used to elicit pri-specific CTL for adoptive immunotherapy
|
Wang, C.
|
|
2003
|
9 |
2 |
p. 95-
1 p.
|
artikel
|
| 71 |
61 Detection of peptide-specific alloreactive T cells using HLA class I tetramers
|
Whitelegg, A.M.
|
|
2003
|
9 |
2 |
p. 83-
1 p.
|
artikel
|
| 72 |
267Developing a data system to monitor infectious complications and make clinical decisions based on readily accessible data
|
Johns, A.A.
|
|
2003
|
9 |
2 |
p. 141-
1 p.
|
artikel
|
| 73 |
284Development and utilization of a unified strategic business plan for marketing blood and marrow transplant outpatient clinic services the goal is to increase awareness of outpatient transplants and increase referrals
|
Mehane, J.J.
|
|
2003
|
9 |
2 |
p. 145-146
2 p.
|
artikel
|
| 74 |
254Digene hybrid capture (DHC) CMV DNA assay compared to CMV culture and incidence of CMV disease in allogeneic hematopoietic stem cell transplantation (ASCT)
|
Trevino, A.
|
|
2003
|
9 |
2 |
p. 137-
1 p.
|
artikel
|
| 75 |
276Discharge planning can make the difference: The Duke Pediatric stem cell translant accelerated discharge model
|
Gurganus, K.J.
|
|
2003
|
9 |
2 |
p. 143-144
2 p.
|
artikel
|
| 76 |
119DLA-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model
|
Fukuda, T.
|
|
2003
|
9 |
2 |
p. 100-101
2 p.
|
artikel
|
| 77 |
82 DNA based high resolution typing: Optimized preselection for confirmatory typing (CT)
|
Wittrock, J.
|
|
2003
|
9 |
2 |
p. 89-
1 p.
|
artikel
|
| 78 |
54 Donor CD4+CD25+ regulatory T-cells, A CD4+ population capable of supporting hematopoietic engraftment without inducing GVHD
|
Hanash, A.M.
|
|
2003
|
9 |
2 |
p. 81-
1 p.
|
artikel
|
| 79 |
106Donor CD8 T-cell support of hematopoietic progenitor activity during syngeneic BMT
|
Hanash, A.M.
|
|
2003
|
9 |
2 |
p. 96-97
2 p.
|
artikel
|
| 80 |
137Donor lymphocyte infusion (DLI) from a HLA identical sibling to treat a complete digeorge anomaly (CDGA)
|
Cellot, S.
|
|
2003
|
9 |
2 |
p. 106-
1 p.
|
artikel
|
| 81 |
88 Donor pretreatment with G-CSF prevents chronic graft-versus-host disease after allogeneic stem cell transplantation
|
MacDonald, K.P.
|
|
2003
|
9 |
2 |
p. 91-
1 p.
|
artikel
|
| 82 |
16 Donor pretreatment with progenipoietin-1 prevents acute graft-versus-host disease in an IL-10 dependent fashion and augments the graft-versus-leukemia effect
|
MacDonald, K.P.
|
|
2003
|
9 |
2 |
p. 68-
1 p.
|
artikel
|
| 83 |
192Dose-reduced conditioning with fludarabine/melphalan followed by allogeneic stem cell transplantation for patients with advanced stage II/III multiple myeloma
|
Kröger, N.M.
|
|
2003
|
9 |
2 |
p. 121-
1 p.
|
artikel
|
| 84 |
283Early CMV reactivation is associated with ganciclovir prophilaxis administrated before transplantation
|
Pachanov, E.D.
|
|
2003
|
9 |
2 |
p. 145-
1 p.
|
artikel
|
| 85 |
139EBV-associated lymphoproliferative disorder developing after conditioning with rabbit ATG
|
Peres, E.M.
|
|
2003
|
9 |
2 |
p. 106-
1 p.
|
artikel
|
| 86 |
Editorial Board
|
|
|
2003
|
9 |
2 |
p. A8-
1 p.
|
artikel
|
| 87 |
170Effectiveness of metronidazole on cyclosporine-induced gingivial hyperplasia in bone marrow and kidney transplant patients:A prospective, double-blinded controlled clinical trial
|
Heshmat, A.
|
|
2003
|
9 |
2 |
p. 115-116
2 p.
|
artikel
|
| 88 |
255Effectiveness of recombinant human erythropoetin on red cell transfusions in non-leukemic adult autologous stem cell transplants: A retrospective evaluation
|
Paivanas, N.
|
|
2003
|
9 |
2 |
p. 137-
1 p.
|
artikel
|
| 89 |
80 Effect of allogeneic stem cell transplantation on bone marrow (BM) angiogenesis in chronic myelogenous leukemia
|
Kumar, S.
|
|
2003
|
9 |
2 |
p. 88-89
2 p.
|
artikel
|
| 90 |
258Efficacy of chlorhexidine dressings for the prevention of catheter entry site infections: Results from a prospective randomised trial in haematology patients receiving chemotherapy
|
Sanders, J.
|
|
2003
|
9 |
2 |
p. 139-
1 p.
|
artikel
|
| 91 |
223Embryonic stem cells survive and proliferate after intra-peritoneal in utero transplantation and produce teratocarcinomas
|
Nedelcu, E.
|
|
2003
|
9 |
2 |
p. 129-
1 p.
|
artikel
|
| 92 |
178Engraftment and production of mesenchymal colony forming cells (M-CFC) in vitro
|
La Russa, V.F.
|
|
2003
|
9 |
2 |
p. 118-
1 p.
|
artikel
|
| 93 |
103Engraftment, GVHD, immune reconstitution and survival following CD8+ T cell depleted allogeneic peripheral blood stem cell transplantation (PBSCT)
|
Soiffer, R.J.
|
|
2003
|
9 |
2 |
p. 95-96
2 p.
|
artikel
|
| 94 |
160Engraftment syndrome in autologous transplantation: A function of CD34+ cell dose
|
Donato, M.L.
|
|
2003
|
9 |
2 |
p. 113-
1 p.
|
artikel
|
| 95 |
129Enhanced T-cell neogenesis following non-myeloablative adult allogeneic hematopoietic stem cell transplantation (NM-HSCT)
|
Hochberg, E.P.
|
|
2003
|
9 |
2 |
p. 103-104
2 p.
|
artikel
|
| 96 |
268Ensuring accuracy of outpatient medication administration for the pediatric bone marrow transplant patient
|
Van Stelle, J.L.
|
|
2003
|
9 |
2 |
p. 141-142
2 p.
|
artikel
|
| 97 |
236Evolving epidemiology of candida in the bone marrow transplant unit: A look twelve years after fluconazole
|
Little, T.B.
|
|
2003
|
9 |
2 |
p. 131-
1 p.
|
artikel
|
| 98 |
41 Extracorporeal photophoresis and pentostatin reduced intensity preparative regimen: Results in patients with myelodysplastic syndrome
|
Chan, G.
|
|
2003
|
9 |
2 |
p. 77-
1 p.
|
artikel
|
| 99 |
155Ex vivo activation and expansion of T cells from the peripheral blood of multiple myeloma patients using the Xcellerate™ process
|
Frohlich, M.W.
|
|
2003
|
9 |
2 |
p. 112-
1 p.
|
artikel
|
| 100 |
172Ex vivo engineering of previously thawed and cryopreserved umbilical cord blood (UCB) with interleukin (IL)-2, IL-7, IL-12 and anti-CD3 for expansion of cytotoxic T lymphocytes (CTL): Promising strategy for adoptive cellular immunotherapy (ACI) post UCB transplantation (T)
|
Cairo, M.S.
|
|
2003
|
9 |
2 |
p. 116-
1 p.
|
artikel
|
| 101 |
247Ex vivo expanded (EYE) peripheral blood progenitor cells (PBPC) demonstrate respiratory burst(RB) and phagocytic capacity: A flow cytometric analysis
|
Tomblyn, M.R.
|
|
2003
|
9 |
2 |
p. 135-
1 p.
|
artikel
|
| 102 |
70 Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors
|
Switzer, G.E.
|
|
2003
|
9 |
2 |
p. 85-86
2 p.
|
artikel
|
| 103 |
204Favorable results of unrelated umbilical cord blood transplantation in pediatric patients with chronic myelogenous leukemia
|
Kurtzberg, J.
|
|
2003
|
9 |
2 |
p. 124-
1 p.
|
artikel
|
| 104 |
179Flow cytometric analysis of cellular differentiation arrest in myelodysplastic syndrome
|
Sherman, M.
|
|
2003
|
9 |
2 |
p. 118-
1 p.
|
artikel
|
| 105 |
162Fludarabine pretreatment and CD34+ yields in non-hodgkins lymphoma stem cell patients
|
Paivanas, N.
|
|
2003
|
9 |
2 |
p. 114-
1 p.
|
artikel
|
| 106 |
130Functional analyses of cytomegalovirus-specific long-term memory effector cells
|
Koehne, G.
|
|
2003
|
9 |
2 |
p. 104-
1 p.
|
artikel
|
| 107 |
270Future fungal fighters
|
Rivera, Z.R.
|
|
2003
|
9 |
2 |
p. 142-
1 p.
|
artikel
|
| 108 |
125Haploidentical CD34 positive cell transplantation in patients with hematological malignancies
|
Taniguchi, S.
|
|
2003
|
9 |
2 |
p. 102-
1 p.
|
artikel
|
| 109 |
11 High incidence of Epstein-Barr virus lymphoproliferative disease (EBV-LPD) after CD34-selected autologous peripheral blood stem cell transplant (PBSCT) in children with neuroblastoma(NB)
|
Grupp, S.
|
|
2003
|
9 |
2 |
p. 66-
1 p.
|
artikel
|
| 110 |
206HLA-identical allogenicc peripheral blood stem cell transplantation in homozygous β thalassemia and severe β thalassemia/hemoglobin E disease patients
|
Pakakasama, S.
|
|
2003
|
9 |
2 |
p. 125-
1 p.
|
artikel
|
| 111 |
84 Host-reactive memory T lymphocytes alone do not induce more severe graft-versus-host disease
|
Chen, B.J.
|
|
2003
|
9 |
2 |
p. 90-
1 p.
|
artikel
|
| 112 |
20 Human cytomegalovirus infection impairs immune phenotype and function of immature and mature monocyte-derived dendritic cells through distinct mechanisms
|
Senechal, B.
|
|
2003
|
9 |
2 |
p. 69-
1 p.
|
artikel
|
| 113 |
194Idiotype vaccination following high dose chemotherapy + autologous stem cell transplant in indolent and mantle cell lymphoma
|
Holman, P.R.
|
|
2003
|
9 |
2 |
p. 121-
1 p.
|
artikel
|
| 114 |
21 IL-15 administration after allogeneic HSCT enhances CD8+T (and NK/T) cell reconstitution through increased homeostatic proliferation without aggravating GVHD
|
Alpdogan, O.
|
|
2003
|
9 |
2 |
p. 69-
1 p.
|
artikel
|
| 115 |
148Immunoablative therapy with purified autologous stem cells rescue for the treatment of poor prognosis MS
|
Atkins, H.L.
|
|
2003
|
9 |
2 |
p. 110-
1 p.
|
artikel
|
| 116 |
216Immunotherapy and single agent chemotherapy in metastatic breast cancer
|
Dicke, K.
|
|
2003
|
9 |
2 |
p. 128-
1 p.
|
artikel
|
| 117 |
277Implementation of a process initiative on the blood and marrow transplant unit that has increased overall family satisfaction with quality of care
|
Cuthrell, P.
|
|
2003
|
9 |
2 |
p. 144-
1 p.
|
artikel
|
| 118 |
96 Improved outcome in acute lethal murine graft versus host disease (GVHD) following administration of the proteasome inhibitor PS-341
|
Welniak, L.A.
|
|
2003
|
9 |
2 |
p. 93-94
2 p.
|
artikel
|
| 119 |
263Improving and standardizing patient education: A patient's resource guide accross the continuum of care for blood and marrow transplantation
|
Jewell, J.
|
|
2003
|
9 |
2 |
p. 140-
1 p.
|
artikel
|
| 120 |
9Improving outcomes of haploidentical transplants for acute leukemia
|
Aversa, F.
|
|
2003
|
9 |
2 |
p. 65-66
2 p.
|
artikel
|
| 121 |
58 Improving transplant revenue management in a multi-hospital transplant enterprise
|
Ball, K.
|
|
2003
|
9 |
2 |
p. 82-
1 p.
|
artikel
|
| 122 |
81 Infections after allogeneic bone marrow transplantation (allo-BMT) in South Brazil: Low incidence of invasive fungal infections despite low-dose fluconazole prophylaxis
|
Bittencourt, H.
|
|
2003
|
9 |
2 |
p. 89-
1 p.
|
artikel
|
| 123 |
104Infliximab for GVHD therapy in children
|
Sleight, B.
|
|
2003
|
9 |
2 |
p. 96-
1 p.
|
artikel
|
| 124 |
34 Influenza infections after stem cell transplantation (SCT): Risk factors, mortality and the effect of antiviral therapy
|
Nichols, W.G.
|
|
2003
|
9 |
2 |
p. 73-74
2 p.
|
artikel
|
| 125 |
98 Infusion of high numbers of G-CSF mobilized blood dendritic cells type 2 (DC-2) is associated with an increased rate of chronic GVHD in allogeneic PBSC transplantation
|
Rondelli, D.
|
|
2003
|
9 |
2 |
p. 94-
1 p.
|
artikel
|
| 126 |
18 Interleukin-10 and tumour necrosis factor alpha haplotypes predict transplant related mortality after unrelated donor stem cell transplants
|
Hows, J.M.
|
|
2003
|
9 |
2 |
p. 68-69
2 p.
|
artikel
|
| 127 |
55 Intravenous busulfan conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity
|
Shimoni, A.
|
|
2003
|
9 |
2 |
p. 81-
1 p.
|
artikel
|
| 128 |
Introductory Remarks
|
|
|
2003
|
9 |
2 |
p. A1-
1 p.
|
artikel
|
| 129 |
174In vitro priming and expansion of CMV-specific THI and TCI T cells from naive cord blood lymphocytes by autologous dendritic cells
|
Szabolcs, P.
|
|
2003
|
9 |
2 |
p. 117-
1 p.
|
artikel
|
| 130 |
24 In vivo purging and post transplant immunotherapy with rituximab produces durable remissions in patients with low grade and mantle cell lymphoma
|
Flinn, I.W.
|
|
2003
|
9 |
2 |
p. 70-71
2 p.
|
artikel
|
| 131 |
244Liposomal amphotericin B (AMB) prophylaxis is safe and effective in preventing invasive fungal infections (IFI) in related and unrelated allogeneic stem cell transplantation (ASCT)
|
Osunkwo, L.
|
|
2003
|
9 |
2 |
p. 134-
1 p.
|
artikel
|
| 132 |
28 Long-term analysis of high-risk primary breast cancer patients enrolled in prospective trials of high-dose chemotherapy (HDC) and autologous hematopoietic progenitor cell transplant (AHPCT)
|
Nieto, Y.
|
|
2003
|
9 |
2 |
p. 72-
1 p.
|
artikel
|
| 133 |
40 Long term comparison of relapse and overall survival in patients with chronic myeloid leukemia (CML) and acute lymphocytic leukemia (all) treated with unrelated or related donor allogeneic marrow/stem cell transplantation
|
Al-Sukbun, S.A.
|
|
2003
|
9 |
2 |
p. 76-77
2 p.
|
artikel
|
| 134 |
145Low toxicity and efficacy of 153-samarium-EDTMP/MELPHALAN as a conditioning regimen for secondary acute myelogenous leukemia
|
Rodriguez, V.
|
|
2003
|
9 |
2 |
p. 108-
1 p.
|
artikel
|
| 135 |
138Lymphocyte recovery after allogeneic stem cell transplantation: Comparison of bone marrow and peripheral blood stem cell transplantation
|
Kumar, S.
|
|
2003
|
9 |
2 |
p. 106-
1 p.
|
artikel
|
| 136 |
49 Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis (HC) after hematopoietic stem cell transplantation (HSCT)
|
Asano, Y.
|
|
2003
|
9 |
2 |
p. 79-
1 p.
|
artikel
|
| 137 |
19 Maturation stage of cord blood natural killer cells
|
Duval, M.
|
|
2003
|
9 |
2 |
p. 69-
1 p.
|
artikel
|
| 138 |
59 Medi-transplantation after intermediate intensity of BU (12MG) /CY (120MG) conditioning regimen
|
Liu, D.
|
|
2003
|
9 |
2 |
p. 82-
1 p.
|
artikel
|
| 139 |
51 Mismatched unrelated cord blood transplantation following reduced-intensity conditioning regimen (RICBT) in adults with hematological diseases and solid malignancies
|
Yuji, K.
|
|
2003
|
9 |
2 |
p. 80-
1 p.
|
artikel
|
| 140 |
280Missed appointments: What are they and why do they happen?
|
Hughes, S.E.
|
|
2003
|
9 |
2 |
p. 144-145
2 p.
|
artikel
|
| 141 |
180Mobilization of peripheral blood progenitor cells (PBPC) with combination of cytokines in autologous and allogeneic pediatric transplant
|
Guerra, J.A.
|
|
2003
|
9 |
2 |
p. 118-119
2 p.
|
artikel
|
| 142 |
169Mobilization of type 1 and type 2 dendritic cells by GM-CSF alone or in combination with G-CSF
|
Gao, H.
|
|
2003
|
9 |
2 |
p. 115-
1 p.
|
artikel
|
| 143 |
167Mobilized peripheral blood contains primitive hematopoietic cells that can be enumerated and isolated using a fluorescent substrate for aldehyde dehydrogenase activity
|
Fallon, P.
|
|
2003
|
9 |
2 |
p. 115-
1 p.
|
artikel
|
| 144 |
105Modulation of host dendritic cells by extracorporeal photophoresis in an allogeneic bone marrow transplant conditioning regimen
|
Chan, G.
|
|
2003
|
9 |
2 |
p. 96-
1 p.
|
artikel
|
| 145 |
195Myeloablative conditioning with TBI/VP-16 with allogeneic stem cell transplantation for multiple myeloma: High response rate and prolonged progression free survival
|
Goldstein, S.C.
|
|
2003
|
9 |
2 |
p. 122-
1 p.
|
artikel
|
| 146 |
6Myocardial angiogenesis and myogenesis by direct injection of autologous marrow stem cells in humans
|
Rowlings, P.A.
|
|
2003
|
9 |
2 |
p. 63-64
2 p.
|
artikel
|
| 147 |
69 NMDP marrow collection center experience and its effect on cell concentration and cell dose
|
Robinett, P.J.
|
|
2003
|
9 |
2 |
p. 85-
1 p.
|
artikel
|
| 148 |
202Non-myeloablative allogeneic peripheral stem cell transplantation in multiple myeloma: 2 years experience in a single center
|
Lie, K.
|
|
2003
|
9 |
2 |
p. 124-
1 p.
|
artikel
|
| 149 |
205Non-myeloablative allogenic stem cell transplant (NASCT) with unrelated cord blood and matched family donors in children and adolescents
|
Satwani, P.
|
|
2003
|
9 |
2 |
p. 125-
1 p.
|
artikel
|
| 150 |
196Non-Myeloablative Stem Cell Transplantation (SCT) is safe and effective for patients with multiple myeloma
|
Moreb, J.S.
|
|
2003
|
9 |
2 |
p. 122-
1 p.
|
artikel
|
| 151 |
168Normal and neoplastic B cells are unduly susceptible to photodynamic cell therapy
|
Roy, D.C.
|
|
2003
|
9 |
2 |
p. 115-
1 p.
|
artikel
|
| 152 |
193Normal hematopoietic stem cell function in mice following treatment with bortezomib
|
Pitzgerald, M.
|
|
2003
|
9 |
2 |
p. 121-
1 p.
|
artikel
|
| 153 |
153Novel high dose chemotherapy regimen for autologous transplant in patients with Hodgkin's disease
|
Garry McCoy, A.
|
|
2003
|
9 |
2 |
p. 111-
1 p.
|
artikel
|
| 154 |
215NS1 and NS2 subpopulations of bone marrow natural suppressor cells
|
Belyaev, N.
|
|
2003
|
9 |
2 |
p. 127-128
2 p.
|
artikel
|
| 155 |
264Nurse's role in recognizing and treating "engraftment syndrome"
|
Causton, C.A.
|
|
2003
|
9 |
2 |
p. 140-
1 p.
|
artikel
|
| 156 |
239Olanzapine for persistent nausea and anorexia after hematopoietic stem cell transplantation
|
Burzynski, J.A.
|
|
2003
|
9 |
2 |
p. 132-
1 p.
|
artikel
|
| 157 |
173Once and twice filgrastim for allogeneic PBSCmobilization
|
Yuji, K.
|
|
2003
|
9 |
2 |
p. 116-117
2 p.
|
artikel
|
| 158 |
229Optical imaging of early post-transplant destiny of bone marrow progenitor cells in mice
|
Doubrovin, M.M.
|
|
2003
|
9 |
2 |
p. 130-131
2 p.
|
artikel
|
| 159 |
121Optimal selective typing strategies for donor registries
|
Müller, C.R.
|
|
2003
|
9 |
2 |
p. 101-
1 p.
|
artikel
|
| 160 |
12 Optimal use of peripheral CD34 counts (PCD34) to guide leukapheresis in autologous peripheral hematopoietic stem cell transplantation (PHSCT)
|
Griffin, D.L.
|
|
2003
|
9 |
2 |
p. 66-67
2 p.
|
artikel
|
| 161 |
238Oral (PO) Valganciclovir (VGC) for preemptive therapy of Cytomegalovirus (CMV) Antigenemia (AG) in hematopoietic stem cell transplant (HSCT) recipients
|
Leather, H.L.
|
|
2003
|
9 |
2 |
p. 132-
1 p.
|
artikel
|
| 162 |
144Outcome of hematopoietic progenitor cells transplant in patients with acute myelogenous leukemia in first complete remission report form a single institution
|
Milone, G.A.
|
|
2003
|
9 |
2 |
p. 108-
1 p.
|
artikel
|
| 163 |
177Outcome of patients treated with high dose melphalan with or without TBI followed by CD34 selected stem cell rescue using the Baxter Isolex 3001
|
Broun, E.R.
|
|
2003
|
9 |
2 |
p. 118-
1 p.
|
artikel
|
| 164 |
213Outcome of pediatric patients who undergo hematopoitic Stem Cell Transplantation (HSCT) for monosomy 7 and other cytiogenetically abnormal Myelodysplastic Syndromes (MDS) or Acute Non-lymphoblastic Leukemia (ANLL) a single institution experience
|
Kletzel, M.
|
|
2003
|
9 |
2 |
p. 127-
1 p.
|
artikel
|
| 165 |
122Outcome of unrelated umbilical cord-blood transplants (UCBT) in pediatric patients: Experience of one center
|
Rodriguez-Marino, S.
|
|
2003
|
9 |
2 |
p. 101-102
2 p.
|
artikel
|
| 166 |
50 Outcomes of HLA identical siblings are comparable to unrelated hematopoietic stem cell transplantation (HSCT) in adults with acute myeloid leukemia
|
Basara, N.
|
|
2003
|
9 |
2 |
p. 80-
1 p.
|
artikel
|
| 167 |
151Parameters for optimal timing for hematopoietic progenitor cell collection
|
Kok, B.
|
|
2003
|
9 |
2 |
p. 110-111
2 p.
|
artikel
|
| 168 |
273Penny wise but pound foolish: Do cost reduction iniatives really work in the pediatric stem cell transplant population?
|
Frey, M.A.
|
|
2003
|
9 |
2 |
p. 143-
1 p.
|
artikel
|
| 169 |
185Performance of young long term survivors after allogeneic Stem Cell Transplantation (SCT)
|
Laursen, H.B.
|
|
2003
|
9 |
2 |
p. 119-120
2 p.
|
artikel
|
| 170 |
42 Peripheral blood stem cell versus marrow donation: Experiences of 942 NMDP donors
|
Switzer, G.E.
|
|
2003
|
9 |
2 |
p. 77-
1 p.
|
artikel
|
| 171 |
243Pharmacoeconomics of prophylaxis for fungal infections in patients undergoing a hematopoietic stem cell transplant
|
Tong, K.B.
|
|
2003
|
9 |
2 |
p. 133-134
2 p.
|
artikel
|
| 172 |
211Pharmacokinetics of IV Busulfan (IV BU) in pediatric infants (< 10-kilogram body weight) undergoing stem cell transplant
|
Dalle, J.
|
|
2003
|
9 |
2 |
p. 126-127
2 p.
|
artikel
|
| 173 |
210Pharmacokinetic study of rabbit anti-thymocyte globulin in children undergoing bone marrow transplantation
|
Chang, C.Y.
|
|
2003
|
9 |
2 |
p. 126-
1 p.
|
artikel
|
| 174 |
102Phase III trial with infliximab/methylprednisolone (MP) vs MP for the treatment of acute GVHD: Preliminary findings
|
Couriel, D.R.
|
|
2003
|
9 |
2 |
p. 95-
1 p.
|
artikel
|
| 175 |
110Phase II study of denileukin diftitox (Ontak) in the treatement of steroid resistant acute graft versus host disease (AGVHD)
|
Shaughnessy, P.
|
|
2003
|
9 |
2 |
p. 98-
1 p.
|
artikel
|
| 176 |
23 Post-traumatic growth: A late effect of stem cell transplantation
|
Bishop, M.M.
|
|
2003
|
9 |
2 |
p. 70-
1 p.
|
artikel
|
| 177 |
241Predominance of resistant gram positive isolates as sources of bacteremia in GVHD patients treated with infliximab
|
Hicks, K.
|
|
2003
|
9 |
2 |
p. 133-
1 p.
|
artikel
|
| 178 |
226Preferential expansion of cord blood early progenitors enabled by linear polyamine copper chelators
|
Peled, T.
|
|
2003
|
9 |
2 |
p. 129-130
2 p.
|
artikel
|
| 179 |
107Prevention of platelet TA-GVHD by use of intercept blood system
|
Lin, L.
|
|
2003
|
9 |
2 |
p. 97-
1 p.
|
artikel
|
| 180 |
30 Prognostic analysis of the early lymphocyte recovery in patients (PTS) with advanced breast cancer receiving high-dose chemotherapy (HDC) with an autologous hematopoietic progenitor cell transplant
|
Nieto, Y.
|
|
2003
|
9 |
2 |
p. 72-73
2 p.
|
artikel
|
| 181 |
251Prognostic factors for day 100 transplant related mortality (Day 100 TRM) following hematopoietic stem cell transplantation (HSCT): A retrospective analysis of 459 patients transplanted at a single institution
|
Mori, S.
|
|
2003
|
9 |
2 |
p. 136-
1 p.
|
artikel
|
| 182 |
250Program overview: Diseases treated, types of transplants, regimens and outcome in an outpatient blood and marrow transplant program
|
Wilson, M.C.
|
|
2003
|
9 |
2 |
p. 136-
1 p.
|
artikel
|
| 183 |
45 Prospective MRD monitoring by RQ-PCR; clinical feasibility in early detection and management of CML relapse after allogeneic SCT
|
Kim, D.
|
|
2003
|
9 |
2 |
p. 78-
1 p.
|
artikel
|
| 184 |
37 Pulmonary hypertension (PH) complicating allogeneic hemapoietic stem cell transplant (HSCT) in children and adolescents
|
Giller, R.H.
|
|
2003
|
9 |
2 |
p. 74-75
2 p.
|
artikel
|
| 185 |
261Quality improvement: Interdisciplinary teams start your binders!
|
Sorensen, S.L.
|
|
2003
|
9 |
2 |
p. 139-140
2 p.
|
artikel
|
| 186 |
184Quality of life in patients with chronic graft vs host disease: A quality process improvement in blood and marrow transplantation
|
Neumann, J.L.
|
|
2003
|
9 |
2 |
p. 119-
1 p.
|
artikel
|
| 187 |
186Quality of Life (QOL) after allogeneic stem cell transplantation: Prospective study of predictors of impaired QOL
|
Okamoto, S.
|
|
2003
|
9 |
2 |
p. 120-
1 p.
|
artikel
|
| 188 |
78 Quantitative detection of chimerism after allogeneic peripheral blood stem cell transplantation
|
Ding-Ping, C.
|
|
2003
|
9 |
2 |
p. 88-
1 p.
|
artikel
|
| 189 |
116Rapid engraftment is associated with an increased incidence of graft vs host disease (GVHD) in children following reduced-intensity hematopoietic stem cell transplantation (RI-HSCT)
|
Bruckner, L.
|
|
2003
|
9 |
2 |
p. 99-100
2 p.
|
artikel
|
| 190 |
134Rapid reconstitution of serum anti-PRP antibody levels in recipients of allogeneic marrow transplantation
|
Bolotin, E.
|
|
2003
|
9 |
2 |
p. 105-
1 p.
|
artikel
|
| 191 |
128Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation
|
McQueen, K.L.
|
|
2003
|
9 |
2 |
p. 103-
1 p.
|
artikel
|
| 192 |
221Reconstitution of vascular endothelium following transplantation of bone marrow derived stem cells
|
Fleming, W.H.
|
|
2003
|
9 |
2 |
p. 128-
1 p.
|
artikel
|
| 193 |
171Recovery of leukocytes from cord blood units after controlled rate freeze in DMSO and cryopreservation in the vapor phase of liquid nitrogen
|
Lane, T.A.
|
|
2003
|
9 |
2 |
p. 116-
1 p.
|
artikel
|
| 194 |
26 Reduced early transplant-related mortality following allogeneic stem cell transplantation (SCT) with fludarabine-based, reduced-intensity conditioning from matched related and unrelated donors in advanced Hodgkin's disease (HD)
|
Anderlini, P.
|
|
2003
|
9 |
2 |
p. 71-
1 p.
|
artikel
|
| 195 |
57 Reduced-intensity conditioning stem cell transplant (RIC-SCT) with fludarabine/busulfan/ATG for hematopoietic malignancies
|
McGuirk, J.
|
|
2003
|
9 |
2 |
p. 82-
1 p.
|
artikel
|
| 196 |
76 Regimen-related toxicity (RRT) following reduced-intensity hematopoietic stem-cell transplantation (RIST): Comparison of bearman's criteria and NCI-CTC version 20
|
Imataki, O.
|
|
2003
|
9 |
2 |
p. 87-
1 p.
|
artikel
|
| 197 |
150Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation: A pilot study
|
Porrata, L.F.
|
|
2003
|
9 |
2 |
p. 110-
1 p.
|
artikel
|
| 198 |
220Repair of infarcted heart by embryonic stem cells
|
Feng, Z.
|
|
2003
|
9 |
2 |
p. 128-
1 p.
|
artikel
|
| 199 |
75 Replacement donor program: The duty to protect stem cell donors from multiple donations for different patients
|
Gawellek, A.
|
|
2003
|
9 |
2 |
p. 87-
1 p.
|
artikel
|
| 200 |
159Requiring more than two apheresis procedures impacts adversely on outcome of autologous peripheral blood stem cell transplantation
|
Nieder, M.L.
|
|
2003
|
9 |
2 |
p. 113-
1 p.
|
artikel
|
| 201 |
87 Residual host chemerism and pattern of antigen expression influence the fate of adoptively transferred allogenic T cells
|
Durakovic, N.
|
|
2003
|
9 |
2 |
p. 91-
1 p.
|
artikel
|
| 202 |
212Retrospective comparison of allogeneic stem cell transplantation (SCT) in pediatric patients utilizing Peripheral Blood Stem Cells (PBSC) vs Bone Marrow (BM)
|
Duerst, R.E.
|
|
2003
|
9 |
2 |
p. 127-
1 p.
|
artikel
|
| 203 |
7Risks and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation: The intensity of the conditioning regimen outweighs the effect of acute graft-versus-host disease
|
Fukuda, T.
|
|
2003
|
9 |
2 |
p. 65-
1 p.
|
artikel
|
| 204 |
230Role of graft-facilitatory cells in human engraftment in the NOD-SCID mouse model
|
Rice, A.M.
|
|
2003
|
9 |
2 |
p. 131-
1 p.
|
artikel
|
| 205 |
245Safety of outpatient high dose oral busulfan in patients undergoing hematopoietic cell transplantation (HCT)
|
Emami, M.
|
|
2003
|
9 |
2 |
p. 134-
1 p.
|
artikel
|
| 206 |
164Safety of rituximab following autologous stem cell transplant
|
Calderon, N.
|
|
2003
|
9 |
2 |
p. 114-
1 p.
|
artikel
|
| 207 |
140Safety, tolerability and drug interactions of adjuvant imatinib mesylate (GLEEVEC®) within the first 100 days following stem cell transplantation (SCT) in patients with PH+ CML and PH+ all at high risk for recurrence
|
Sheth, S.R.
|
|
2003
|
9 |
2 |
p. 107-
1 p.
|
artikel
|
| 208 |
111Selective depletion of human GVH-reactive T-cells by anti-CD95 mediated activation-induced cell death or via the T-cell activation antigen CD69 for preventing graft-versus-host disease in allo-BMT
|
Nonn, M.
|
|
2003
|
9 |
2 |
p. 98-
1 p.
|
artikel
|
| 209 |
62 Selectively depleting host-reactive T cells from peripheral blood stem cell allografts — preliminary results of a feasibility study
|
Solomon, S.
|
|
2003
|
9 |
2 |
p. 83-
1 p.
|
artikel
|
| 210 |
112Serum cytokine profiles of patients with acute GVHD treated with methylprednisolone alone or in combination with infliximab are different
|
Lee, B.
|
|
2003
|
9 |
2 |
p. 98-99
2 p.
|
artikel
|
| 211 |
136Sex steroid ablation by castration enhances haemopoietic recovery following allogeneic bone marrow transplantation
|
Goldberg, G.L.
|
|
2003
|
9 |
2 |
p. 105-106
2 p.
|
artikel
|
| 212 |
228Sibling donor cord blood (SDCB) banking and transplantation for children with sickle cell anemia and thalassemia: Childrens hospital Oakland sibling donor cord blood program
|
Lubin, B.H.
|
|
2003
|
9 |
2 |
p. 130-
1 p.
|
artikel
|
| 213 |
109Single-agent tacrolimus for prophylaxis of acute graft-versus-host disease after related allogeneic peripheral blood stem cell transplantation: A phase II study
|
Schwartz, J.E.
|
|
2003
|
9 |
2 |
p. 97-98
2 p.
|
artikel
|
| 214 |
38 Sirolimus and tacrolimus without methotrexate to prevent graft-vs-host disease after matched, related stem cell transplantation
|
Cutler, C.
|
|
2003
|
9 |
2 |
p. 76-
1 p.
|
artikel
|
| 215 |
15 Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease
|
Couriel, D.R.
|
|
2003
|
9 |
2 |
p. 67-68
2 p.
|
artikel
|
| 216 |
99 Solid tumor vaccines elicit distinct immune responses from host versus donor T cells in mixed chimeras created by non-myeloablative allogeneic stem cell transplantation (NST)
|
Durakovic, N.
|
|
2003
|
9 |
2 |
p. 94-95
2 p.
|
artikel
|
| 217 |
266Sperm quality according to the disease and treatment pre stem cell transplantation
|
Choi, S.
|
|
2003
|
9 |
2 |
p. 141-
1 p.
|
artikel
|
| 218 |
79 Stem cell transplantation in Australia and New Zealand: An update from the Australasian bone marrow transplant recipient registry (ABMTRR)
|
Szer, J.
|
|
2003
|
9 |
2 |
p. 88-
1 p.
|
artikel
|
| 219 |
44 Stem cell transplantation (SCT) for patients with fanconi's anemia (FA) with low dose cyclophosphamide (CY) and antithymocyte globulins (ATG) without the use of radiation therapy, a prospective study
|
Ayas, M.F.
|
|
2003
|
9 |
2 |
p. 78-
1 p.
|
artikel
|
| 220 |
142Successful allogeneic HSCT for consolidation in young children with high-risk 11Q23+ ALL in CR1
|
Quinones, R.R.
|
|
2003
|
9 |
2 |
p. 107-
1 p.
|
artikel
|
| 221 |
257Sudden bilateral visual loss due to disseminated fusariosis diagnosed by culture and polymerase chain reaction
|
Vazquez, J.A.
|
|
2003
|
9 |
2 |
p. 137-138
2 p.
|
artikel
|
| 222 |
48 Sustained engraftment of HLA-matched related, T-cell depleted (TCD), peripheral blood stem cell (PBSC)/bone marrow (BM) transplants in adults with hematologic malignancies without the use of antithymocyte globulin (ATG)
|
Jakubowski, A.A.
|
|
2003
|
9 |
2 |
p. 79-
1 p.
|
artikel
|
| 223 |
187Systematic review of the literature regarding family impact when an adult member experiences bone marrow transplantation
|
Young, L.K.
|
|
2003
|
9 |
2 |
p. 120-
1 p.
|
artikel
|
| 224 |
94 Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in allogeneic SCT (alloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with AGVHD
|
Bessmertny, O.
|
|
2003
|
9 |
2 |
p. 93-
1 p.
|
artikel
|
| 225 |
91 T-cell apoptosis following non-myeloablative hematopoietic cell transplantation (HCT)
|
Bhushan, V.
|
|
2003
|
9 |
2 |
p. 92-
1 p.
|
artikel
|
| 226 |
71 T-cell depleted allogeneic bone marrow transplantation followed by T cell add-back in patients with multiple myeloma
|
Magalhaes-Silverman, M.
|
|
2003
|
9 |
2 |
p. 86-
1 p.
|
artikel
|
| 227 |
131T cell function and cytokines in autologous PBSC transplantation: Comparative analysis of immune cell populations within the PBSC graft vs blood post transplant
|
Goldman, F.D.
|
|
2003
|
9 |
2 |
p. 104-
1 p.
|
artikel
|
| 228 |
86 TCR transgenic hematopoetic stem cells engraft into non-transgenic recipients and evolve antigen-specific T-cells
|
Kraft, D.L.
|
|
2003
|
9 |
2 |
p. 90-91
2 p.
|
artikel
|
| 229 |
43 Test dose pharmacokinetics (PK) directed intravenous busulfan (IVBU) dosing for hematopoietic stem cell transplant (HSCT) preparative regimens
|
Dickey, A.G.
|
|
2003
|
9 |
2 |
p. 77-78
2 p.
|
artikel
|
| 230 |
133TH1 and TH2 cytokine syntheses by T cells of recipients of G-CSF mobilized allogeneic PBSC
|
Lee, B.
|
|
2003
|
9 |
2 |
p. 105-
1 p.
|
artikel
|
| 231 |
124The absence of MHC class I on neural stem cells does not permit NK killing and prevents recognition by alloreactive CTL
|
Mammolenti, M.
|
|
2003
|
9 |
2 |
p. 102-
1 p.
|
artikel
|
| 232 |
163The administrative challenge in the development of a point of service clinic for post blood and marrow transplantation patients
|
Adornetto, D.L.
|
|
2003
|
9 |
2 |
p. 114-
1 p.
|
artikel
|
| 233 |
65 The CD4 peptide analogue 802-2 inhibits proliferation of both TH1 and TH2 cells in response to allogeneic stimulation
|
Zhu, Z.
|
|
2003
|
9 |
2 |
p. 84-
1 p.
|
artikel
|
| 234 |
198The choice of conditioning regimen regarding the host T-cell levels seems to be an effective way how to achieve the donor cells engraftment including effective tumour control and reduce the toxicity of some non-myeloablative allogeneic stem cell transplantations in lymphomas
|
Raida, L.
|
|
2003
|
9 |
2 |
p. 122-123
2 p.
|
artikel
|
| 235 |
271The complexity of transitioning blood and marrow patients from outpatient to inpatient
|
Calamusa, J.M.
|
|
2003
|
9 |
2 |
p. 142-
1 p.
|
artikel
|
| 236 |
161The effect of glutamine on disease progression in multiple myeloma (MM) patients receiving high-dose melphalan
|
Crook, J.L.
|
|
2003
|
9 |
2 |
p. 113-114
2 p.
|
artikel
|
| 237 |
154The impact of stem cell transplantation on mantle cell lymphoma
|
Logsdon, M.S.
|
|
2003
|
9 |
2 |
p. 111-112
2 p.
|
artikel
|
| 238 |
114The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation
|
Penteado, Aranha F.J.
|
|
2003
|
9 |
2 |
p. 99-
1 p.
|
artikel
|
| 239 |
92 The leukemia-associated antigen PRI is derived from both proteinase 3 and neutrophil elastase proteins
|
Ono, Y.
|
|
2003
|
9 |
2 |
p. 92-93
2 p.
|
artikel
|
| 240 |
73 The ottawa 10-year experience in allogeneic stem cell transplantation for follicular lymphoma
|
Sabloff, M.
|
|
2003
|
9 |
2 |
p. 86-87
2 p.
|
artikel
|
| 241 |
227The presence CXCR4 on CD34+ cells was associated with the effectiveness of G-CSF PBPC mobilization
|
Lange, A.
|
|
2003
|
9 |
2 |
p. 130-
1 p.
|
artikel
|
| 242 |
22 The prevalence and severity of fatigue in long-term survivors of allogeneic stem cell transplantation: A preliminary analysis
|
Kaur, B.
|
|
2003
|
9 |
2 |
p. 70-
1 p.
|
artikel
|
| 243 |
33 The role of B-catenin in chronic myelogenous leukemic compared with normal human hematopoietic stem cell and myeloid progenitor expansion
|
Jamieson, C.H.
|
|
2003
|
9 |
2 |
p. 73-
1 p.
|
artikel
|
| 244 |
118The role of digital photography in the documentation of skin graft versus host disease
|
Marquesen, M.
|
|
2003
|
9 |
2 |
p. 100-
1 p.
|
artikel
|
| 245 |
77 The role of low dose busulfan (BU) (4MG/KG) with cyclophosphamide (CY) as a conditioning regimen for severe aplastic anaemia (SAA)
|
Dulley, F.L.
|
|
2003
|
9 |
2 |
p. 88-
1 p.
|
artikel
|
| 246 |
260The tandem autologous and matched related nonmyeloablative HSCT patient: What's different?
|
Anderson, I.A.
|
|
2003
|
9 |
2 |
p. 139-
1 p.
|
artikel
|
| 247 |
132The T lymphocyte response to aspergillus (ASP) results in rapid TNF-α, IFN-γand IL-2 intracellular cytokine (ICC) production and can occur without APCS
|
Hensel, N.
|
|
2003
|
9 |
2 |
p. 104-105
2 p.
|
artikel
|
| 248 |
25 The use of EBV-specific cytotoxic T lymphocytes as adjuvant therapy post stem cell transplant for relapsed EBV-positive Hodgkin disease
|
Bollard, C.M.
|
|
2003
|
9 |
2 |
p. 71-
1 p.
|
artikel
|
| 249 |
157Thrombotic microangiopathy (TMA), encephalitis, and seizures due to human herpes virus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation (ASCT)
|
Belford, A.M.
|
|
2003
|
9 |
2 |
p. 112-113
2 p.
|
artikel
|
| 250 |
282Thrombotic thrombocytopenia purpura and hemolytic uremic syndrome in bone marrow transplant
|
Shelburne, N.F.
|
|
2003
|
9 |
2 |
p. 145-
1 p.
|
artikel
|
| 251 |
67 Thrombotic thrombocytopenic purpura following bone marrow transplant treatment and outcome in ten patients
|
Peres, E.M.
|
|
2003
|
9 |
2 |
p. 85-
1 p.
|
artikel
|
| 252 |
143Thymoglobulin as part of the pre-transplant conditioning for unrelated donor stem-cell transplantation a dose-finding study
|
Remberger, M.P.
|
|
2003
|
9 |
2 |
p. 108-
1 p.
|
artikel
|
| 253 |
176Time-temperature study of cell survival in Bone Marrow (BM) and Blood hematopoietic Progenitor Cell (HPC) grafts
|
Rosenthal, H.S.
|
|
2003
|
9 |
2 |
p. 117-118
2 p.
|
artikel
|
| 254 |
262TIS the reason to be sneezing - RSV
|
Meyers, A.L.
|
|
2003
|
9 |
2 |
p. 140-
1 p.
|
artikel
|
| 255 |
115TNF type II receptor genotype affects soluble receptor levels in normal subjects and associates with chronic GVHD severity
|
Stark, G.
|
|
2003
|
9 |
2 |
p. 99-
1 p.
|
artikel
|
| 256 |
8Trafficking of ex vivo expanded donor derived dendritic cells after allogeneic BMT
|
Schimmelpfennig, C.H.
|
|
2003
|
9 |
2 |
p. 65-
1 p.
|
artikel
|
| 257 |
97 Treatment of chronic myelogenous leukemia (CML) relapsing after myeloablative stem cell transplantation with STI-571 (imatinib mesylate) with or without donor lymphocyte infusion (DLI)
|
Barrett, J.A.
|
|
2003
|
9 |
2 |
p. 94-
1 p.
|
artikel
|
| 258 |
93 Treatment of donors with interleukin-18 reduces acute graft-versus-host disease via STAT6 and preserves CD8+ mediated graft-versus-leukemia effects
|
Reddy, P.
|
|
2003
|
9 |
2 |
p. 93-
1 p.
|
artikel
|
| 259 |
272Treatment plans for blood and marrow transplantation patients; the communication link
|
Stary, S.J.
|
|
2003
|
9 |
2 |
p. 142-143
2 p.
|
artikel
|
| 260 |
2Two HLA-A2-restricted peptides from cyclin E1 and cyclin E2 elicit CTL that kill myeloid leukemia cell line
|
Kondo, Y.
|
|
2003
|
9 |
2 |
p. 61-
1 p.
|
artikel
|
| 261 |
222Umbilical cord blood cells engraft and differentiate in neural tissues after human transplantation
|
Kurtzberg, J.
|
|
2003
|
9 |
2 |
p. 128-129
2 p.
|
artikel
|
| 262 |
47 Universal outpatient immunotherapeutic approach for heme malignancies in the absence of donor chimerism: Anti-tumor responses in HLA-Haploidentical cell infusions in 100CGY treated hosts
|
Colvin, G.A.
|
|
2003
|
9 |
2 |
p. 79-
1 p.
|
artikel
|
| 263 |
120Unrelated cord blood transplantation (UCBT) from HLA disparate donors results in a very low risk of ≥grade II acute & chronic GVHD: CD34 dose and non-TBI conditioning predict for significantly improved survival
|
Styczynski, J.
|
|
2003
|
9 |
2 |
p. 101-
1 p.
|
artikel
|
| 264 |
5Unrelated umbilical cord blood transplantation for hurler syndrome
|
Staba, S.L.
|
|
2003
|
9 |
2 |
p. 63-
1 p.
|
artikel
|
| 265 |
209Unrelated umbilical cord blood transplantation successfully corrects congenital immunodeficiency syndromes
|
Kurtzberg, J.
|
|
2003
|
9 |
2 |
p. 126-
1 p.
|
artikel
|
| 266 |
175Upregulation of the expression of molecules involved in allorecognition: Implications for potentiating the mixed lymphocyte reaction prior to selective alloreactive T cell depletion
|
Davies, J.K.
|
|
2003
|
9 |
2 |
p. 117-
1 p.
|
artikel
|
| 267 |
248Use of amplicor® CMV monitor(ROCHE)for CMV surveillance after blood and marrow transplantation
|
Mann, L.
|
|
2003
|
9 |
2 |
p. 135-
1 p.
|
artikel
|
| 268 |
256Utilizing a customized epidemiological, drug-susceptibility database to monitor resistance patterns and trends to make appropriate empiric antibiotic selections for blood and marrow transplant recipients
|
White, M.
|
|
2003
|
9 |
2 |
p. 137-
1 p.
|
artikel
|
| 269 |
252Valacyclovir compared to acyclovir for cytomegalovirus prophylaxis in allogeneic stem cell transplants recipients
|
Artz, A.S.
|
|
2003
|
9 |
2 |
p. 136-
1 p.
|
artikel
|
| 270 |
259Validation of the nursing diagnosis anxiety as experienced by adult bone marrow transplant patients from the perspective of the patient, significant other and nurse
|
Young, L.K.
|
|
2003
|
9 |
2 |
p. 139-
1 p.
|
artikel
|
| 271 |
100Vβ repertoire analysis of tissue infiltrating CD8+ Tcells responding to minor histocompatibility antigens involved in graft-versus-host disease
|
Friedman, T.M.
|
|
2003
|
9 |
2 |
p. 95-
1 p.
|
artikel
|
| 272 |
281When dyspnea becomes an oncologic emergency for blood and marrow transplantation (BMT) patients: Diffuse alveolar hemorrhage
|
Hinds, L.
|
|
2003
|
9 |
2 |
p. 145-
1 p.
|
artikel
|
Tijdschrift beschrijving